Key result
Patients with advanced somatic disease (ESRD and breast cancer) revealed higher levels of state and trait anxiety than healthy controls, although the differences did not reach statistical significance.
Cross-Sectional (n=164)
Absolute Event Rate: 49.44% vs 47.05%
p-value: p=>0.05
In patients with advanced somatic diseases like ESRD and breast cancer, non-constructive coping strategies are associated with higher levels of anxiety, highlighting the need for targeted psychological support.
No takes yet. Share an insight, caveat, or question.
Non-significant anxiety elevation in ESRD and breast cancer leaves practice unchanged; hypothesis-generating for coping strategy interventions in advanced somatic disease.
Janiszewska et al. (2012) conducted a cross-sectional in End-stage renal disease and end-stage breast cancer (n=164). Advanced somatic disease (ESRD or breast cancer) vs. Healthy controls was evaluated on State anxiety (measured by STAI in centiles) (p=>0.05). Patients with advanced somatic disease (ESRD and breast cancer) revealed higher levels of state and trait anxiety than healthy controls, although the differences did not reach statistical significance.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: